Vivani Medical Inc.

NASDAQ: VANI · Real-Time Price · USD
1.25
-0.02 (-1.57%)
At close: Aug 15, 2025, 3:59 PM
1.27
1.20%
After-hours: Aug 15, 2025, 07:15 PM EDT

Vivani Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
398K 398K 398K 518K 518K 518K 518K n/a n/a n/a n/a 260.00 260.00 260.00 260.00 0.00 0.00 0.00
Cost of Revenue
214K 314K 311K 409K 368K 348K 357K 369K 559K 490K 382K 272.13K 11.13K 130.00 130.00 500K 500K 500K
Gross Profit
-15K -115K -112K 109K 150K 170K 161K -369K -559K -490K -382K -271.87K -10.87K 130.00 130.00 -500K -500K -500K
Operating Income
-26.79M -25.01M -24.68M -24.43M -25.27M -26.59M -26.96M -28.54M -26.84M -23.92M -21.23M -16.99M -15.03M -13.24M -12.3M -10.03M -8.15M -8.97M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2K 2K 2K 2K 16K
Pretax Income
-25.54M -23.75M -23.49M -23.46M -24.2M -25.37M -25.65M -26.91M -18.7M -16.28M -13.89M -10.22M -15.14M -13.33M -12.39M -10.06M -8.18M -8.98M
Net Income
-25.54M -23.75M -23.49M -23.46M -24.2M -25.37M -25.37M -26.14M -11.07M -8.66M -6.57M -3.39M -15.17M -13.35M -12.39M -10.06M -8.18M -8.98M
Selling & General & Admin
9.31M 8.77M 8.83M 8.09M 8.68M 9.65M 9.9M 11.85M 10.73M 8.48M 7.06M 4.27M 3.3M 3.76M 3.1M 3.87M 4.57M 5.18M
Research & Development
17.48M 16.24M 15.74M 16.15M 16.39M 16.74M 16.97M 16.69M 16.11M 15.44M 14.17M 12.71M 11.72M 9.22M 8.94M 6.32M 3.73M 3.35M
Other Expenses
n/a n/a 99K 197K 197K 674K 858K 756K 760K 267K -33K -29K -39K 240K 245K 328K 334K 71K
Operating Expenses
26.79M 25.01M 24.68M 24.43M 25.27M 26.59M 26.96M 28.54M 26.84M 23.92M 21.23M 16.99M 15.03M 13.24M 12.3M 10.53M 8.65M 8.62M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -99K -197K -197K -197K -98K n/a n/a n/a n/a n/a n/a n/a n/a n/a 261K 690K
Cost & Expenses
26.79M 25.01M 24.68M 24.43M 25.27M 26.59M 26.96M 28.54M 26.84M 23.92M 21.23M 16.99M 15.03M 13.24M 12.3M 10.03M 8.15M 8.12M
Income Tax Expense
n/a n/a n/a n/a n/a -42.09K -325.08K -810.09K -7.68M -7.62M -7.32M -6.83M 15K 1K -16K -16K 1K 15K
Shares Outstanding (Basic)
59.24M 59.24M 57.42M 55.25M 55.02M 52.2M 51.02M 50.84M 50.8M 50.76M 50.74M 37.97M 50.73M 33.09M 39.41M 33.09M 28.67M 33.09M
Shares Outstanding (Diluted)
59.24M 59.24M 57.42M 55.25M 55.02M 52.2M 51.02M 50.84M 50.8M 50.76M 50.74M 38.48M 50.73M 33.09M 39.41M 33.09M 28.67M 33.09M
EPS (Basic)
-0.45 -0.43 -0.44 -0.45 -0.47 -0.5 -0.5 -0.51 -0.16 -0.11 -0.11 -0.07 -0.4 -0.4 -0.37 -0.34 -0.3 -0.37
EPS (Diluted)
-0.45 -0.43 -0.44 -0.45 -0.47 -0.5 -0.5 -0.51 -0.16 -0.11 -0.11 -0.07 -0.4 -0.4 -0.37 -0.34 -0.3 -0.37
EBITDA
-26.48M -24.6M -24.28M -24.02M -24.9M -26.24M -26.61M -28.56M -26.83M -23.91M -21.24M -16.63M -14.69M -12.96M -12.03M -9.84M -8.02M -8.82M
EBIT
-26.47M -25.01M -24.68M -24.43M -25.27M -26.59M -26.96M -28.03M -26.33M -23.42M -20.72M -16.99M -15.03M -13.23M -12.3M -10.04M -8.16M -8.97M
Depreciation & Amortization
303K 403K 400K 409K 368K 348K 357K 369K 559K 566K 541K 514K 271K 203K 208K 141K 145K 146K